Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.

Recent HIV-1 vaccine development has centered on "near native" soluble envelope glycoprotein (Env) trimers that are artificially stabilized laterally (between protomers) and apically (between gp120 and gp41). These mutations have been leveraged for use in membrane-expressed Env mRNA vaccin...

Full description

Saved in:
Bibliographic Details
Main Authors: Tommy Tong, Alessio D'Addabbo, Jiamin Xu, Himanshi Chawla, Albert Nguyen, Paola Ochoa, Max Crispin, James M Binley
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-08-01
Series:PLoS Pathogens
Online Access:https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011452&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850264561787076608
author Tommy Tong
Alessio D'Addabbo
Jiamin Xu
Himanshi Chawla
Albert Nguyen
Paola Ochoa
Max Crispin
James M Binley
author_facet Tommy Tong
Alessio D'Addabbo
Jiamin Xu
Himanshi Chawla
Albert Nguyen
Paola Ochoa
Max Crispin
James M Binley
author_sort Tommy Tong
collection DOAJ
description Recent HIV-1 vaccine development has centered on "near native" soluble envelope glycoprotein (Env) trimers that are artificially stabilized laterally (between protomers) and apically (between gp120 and gp41). These mutations have been leveraged for use in membrane-expressed Env mRNA vaccines, although their effects in this context are unclear. To address this question, we used virus-like particle (VLP) produced in 293T cells. Uncleaved (UNC) trimers were laterally unstable upon gentle lysis from membranes. However, gp120/gp41 processing improved lateral stability. Due to inefficient gp120/gp41 processing, UNC is incorporated into VLPs. A linker between gp120 and gp41 neither improved trimer stability nor its antigenic profile. An artificially introduced enterokinase cleavage site allowed post-expression gp120/gp41 processing, concomitantly increasing trimer stability. Gp41 N-helix mutations I559P and NT1-5 imparted lateral trimer stability, but also reduced gp120/gp41 processing and/or impacted V2 apex and interface NAb binding. I559P consistently reduced recognition by HIV+ human plasmas, further supporting antigenic differences. Mutations in the gp120 bridging sheet failed to stabilize membrane trimers in a pre-fusion conformation, and also reduced gp120/gp41 processing and exposed non-neutralizing epitopes. Reduced glycan maturation and increased sequon skipping were common side effects of these mutations. In some cases, this may be due to increased rigidity which limits access to glycan processing enzymes. In contrast, viral gp120 did not show glycan skipping. A second, minor species of high mannose gp160 was unaffected by any mutations and instead bypasses normal folding and glycan maturation. Including the full gp41 cytoplasmic tail led to markedly reduced gp120/gp41 processing and greatly increased the proportion of high mannose gp160. Remarkably, monoclonal antibodies were unable to bind to this high mannose gp160 in native protein gels. Overall, our findings suggest caution in leveraging stabilizing mutations in nucleic acid-based immunogens to ensure they impart valuable membrane trimer phenotypes for vaccine use.
format Article
id doaj-art-da0b002c81154636a46ef072541aaecf
institution OA Journals
issn 1553-7366
1553-7374
language English
publishDate 2023-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj-art-da0b002c81154636a46ef072541aaecf2025-08-20T01:54:40ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742023-08-01198e101145210.1371/journal.ppat.1011452Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.Tommy TongAlessio D'AddabboJiamin XuHimanshi ChawlaAlbert NguyenPaola OchoaMax CrispinJames M BinleyRecent HIV-1 vaccine development has centered on "near native" soluble envelope glycoprotein (Env) trimers that are artificially stabilized laterally (between protomers) and apically (between gp120 and gp41). These mutations have been leveraged for use in membrane-expressed Env mRNA vaccines, although their effects in this context are unclear. To address this question, we used virus-like particle (VLP) produced in 293T cells. Uncleaved (UNC) trimers were laterally unstable upon gentle lysis from membranes. However, gp120/gp41 processing improved lateral stability. Due to inefficient gp120/gp41 processing, UNC is incorporated into VLPs. A linker between gp120 and gp41 neither improved trimer stability nor its antigenic profile. An artificially introduced enterokinase cleavage site allowed post-expression gp120/gp41 processing, concomitantly increasing trimer stability. Gp41 N-helix mutations I559P and NT1-5 imparted lateral trimer stability, but also reduced gp120/gp41 processing and/or impacted V2 apex and interface NAb binding. I559P consistently reduced recognition by HIV+ human plasmas, further supporting antigenic differences. Mutations in the gp120 bridging sheet failed to stabilize membrane trimers in a pre-fusion conformation, and also reduced gp120/gp41 processing and exposed non-neutralizing epitopes. Reduced glycan maturation and increased sequon skipping were common side effects of these mutations. In some cases, this may be due to increased rigidity which limits access to glycan processing enzymes. In contrast, viral gp120 did not show glycan skipping. A second, minor species of high mannose gp160 was unaffected by any mutations and instead bypasses normal folding and glycan maturation. Including the full gp41 cytoplasmic tail led to markedly reduced gp120/gp41 processing and greatly increased the proportion of high mannose gp160. Remarkably, monoclonal antibodies were unable to bind to this high mannose gp160 in native protein gels. Overall, our findings suggest caution in leveraging stabilizing mutations in nucleic acid-based immunogens to ensure they impart valuable membrane trimer phenotypes for vaccine use.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011452&type=printable
spellingShingle Tommy Tong
Alessio D'Addabbo
Jiamin Xu
Himanshi Chawla
Albert Nguyen
Paola Ochoa
Max Crispin
James M Binley
Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.
PLoS Pathogens
title Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.
title_full Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.
title_fullStr Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.
title_full_unstemmed Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.
title_short Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.
title_sort impact of stabilizing mutations on the antigenic profile and glycosylation of membrane expressed hiv 1 envelope glycoprotein
url https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011452&type=printable
work_keys_str_mv AT tommytong impactofstabilizingmutationsontheantigenicprofileandglycosylationofmembraneexpressedhiv1envelopeglycoprotein
AT alessiodaddabbo impactofstabilizingmutationsontheantigenicprofileandglycosylationofmembraneexpressedhiv1envelopeglycoprotein
AT jiaminxu impactofstabilizingmutationsontheantigenicprofileandglycosylationofmembraneexpressedhiv1envelopeglycoprotein
AT himanshichawla impactofstabilizingmutationsontheantigenicprofileandglycosylationofmembraneexpressedhiv1envelopeglycoprotein
AT albertnguyen impactofstabilizingmutationsontheantigenicprofileandglycosylationofmembraneexpressedhiv1envelopeglycoprotein
AT paolaochoa impactofstabilizingmutationsontheantigenicprofileandglycosylationofmembraneexpressedhiv1envelopeglycoprotein
AT maxcrispin impactofstabilizingmutationsontheantigenicprofileandglycosylationofmembraneexpressedhiv1envelopeglycoprotein
AT jamesmbinley impactofstabilizingmutationsontheantigenicprofileandglycosylationofmembraneexpressedhiv1envelopeglycoprotein